Skip to main content
. 2022 Jan-Feb;37(1):88–98. doi: 10.21470/1678-9741-2020-0146

Table 3.

Baseline characteristics of the included patients. The first number is the number of patients with the event or the sample mean value ± standard deviation of the variable, and the second is the number of patients for whom the event was described. Statistically significant differences were marked with an asterisk (*).

Baseline variable BAV (n=917) TAV (n=3079) OR/WMD [95% CI] P-value
Age (years±SD) 76.8±7.43 78.5±7.12 WMD -0.89 [-1.60, -0.17] 0.02*
Male (%) 562/917 (61.3) 1554/3079 (50.5) OR 1.10 [0.93, 1.31] 0.27
Diabetes mellitus (%) 226/917 (24.6) 980/3079 (31.8) OR 1.00 [0.82, 1.21] 0.98
Previous stroke (%) 130/917 (14.2) 357/3079 (11.6) OR 1.20 [0.94, 1.54] 0.15
Peripheral arterial disease (%) 177/834 (21.2) 690/2913 (23.7) OR 0.95 [0.67, 1.34] 0.76
Hypertension (%) 603/879 (68.6) 1293/1722 (75.1) OR 0.95 [0.78, 1.16] 0.61
COPD (%) 194/834 (23.3) 660/2913 (22.7) OR 1.05 [0.84, 1.32] 0.67
Ischaemic heart disease (%) 175/339 (51.6) 1472/2437 (60.4) OR 0.99 [0.76, 1.29] 0.92
Previous CABG (%) 75/710 (10.6) 340/2178 (15.6) OR 0.85 [0.62, 1.17] 0.33
Previous PCI (%) 180/797 (22.6) 709/2248 (31.5) OR 0.89 [0.71, 1.11] 0.31
NYHA class III-IV (%) 632/797 (79.3) 1874/2248 (83.4) OR 1.09 [0.86, 1.37] 0.48
Atrial fibrillation (%) 49/273 (17.9) 189/996 (19.0) OR 0.94 [0.64, 1.38] 0.74
EuroSCORE (%±SD) 17.4±10.5 19.4±12.6 WMD -1.15 [-2.63, 0.33] 0.13
STS score (%±SD) 6.10±3.88 6.53±3.98 WMD 0.06 [-0.28, 0.40] 0.73
Aortic valve area (cm2±SD) 0.629±0.173 0.660±0.239 WMD -0.03 [-0.06, 0.01] 0.11
Trans-aortic valve gradient (mmHg±SD) 52.6±17.3 49.8±16.1 WMD 1.73 [0.31, 3.16] 0.02*
Aortic annular diameter (mm±SD) 23.6±4.42 24.3±3.72 WMD -0.23 [-1.63, 1.17] 0.74
Left ventricular ejection fraction (%±SD) 51.3±14.2 53.6±13.0 WMD -2.60 [-5.57, 0.37] 0.09
Ascending aortic diameter (mm±SD) 38.4±5.00 34.2±3.63 WMD 3.92 [3.02, 4.83] <0.0001*

BAV=bicuspid aortic valve; CABG=coronary artery bypass graft; CI=confidence interval; COPD=chronic obstructive pulmonary disease; NYHA=New York Heart Association; PCI=percutaneous coronary intervention; STS=Society of Thoracic Surgeons;

WMD=weighted mean difference